Study: Sleeping aids could increase the risk of Alzheimer's
A new study from the University of Washington School of Pharmacy found that over-the-counter sleeping drugs could increase the risk of Alzheimer's disease.
The study, published in the journal JAMA Internal Medicine on Monday, found that some sleep aids and anti-allergy pills contain "anticholinergic" blocking effects, which, if taken in large doses, can increase the risk of dementia and Alzheimer's. Anticholinergic drugs block acetylcholine, a chemical transmitter in the nervous system that Alzheimer's patients often lack.
The researchers suggested that doctors prescribe lower doses and fewer anticholinergic drugs for older patients, though more research is needed to understand sleep aids' potential risks.
The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Join 350,000+ subscribers and keep yourself informed with a selection of The Week’s most interesting, enlightening and entertaining stories - plus daily puzzles.
Meghan DeMaria is a staff writer at TheWeek.com. She has previously worked for USA Today and Marie Claire.
